Chinese expert consensus on clinical management of hepatopathy-related thrombocytopenia (2023 edition)
Hepatology International · 2025
DOI: 10.1007/s12072-024-10755-6 ↗Kurz gefasst
Leitlinie in der Zeitschrift Hepatology International, 2025. Verfasst von Hang Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Hauptthemen laut MEDLINE: Liver Diseases, Thrombocytopenia. Die Arbeit nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatopathy-related thrombocytopenia refers to a reduction in platelet count caused by liver disease or its treatment. The incidence of this condition is correlated with the duration and severity of liver disease. The direct impact of thrombocytopenia on the clinical outcome of patients with liver disease is an increased risk of bleeding. In addition, the indirect effect involves delays or discontinuation of treatment due to the potential risk of bleeding. The pathophysiological mechanisms of hepatopathy-related thrombocytopenia include reduced platelet production, abnormal distribution, increased destruction or consumption, and so on. Current treatment strategies targeting different mechanisms include thrombopoietic agents, surgery, immunosuppressants, and platelet transfusion. However, their clinical application lacks standardization. The National Clinical Research Center for Infectious Diseases organized experts to discuss and develop this consensus to enhance the clinical management level of hepatopathy-related thrombocytopenia in China. The experts focused on aspects of diagnosis, classification, and choosing the best treatment plans based on the most recent research in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Senior Department of Hematology, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
- Comprehensive Liver Cancer Center, The Fifth Medical Center of PLA General Hospital, Beijing, China.
- Senior Department of Infectious Diseases, The Fifth Medical Center of PLA General Hospital, Beijing, China. fswang302@163.com.
- Comprehensive Liver Cancer Center, The Fifth Medical Center of PLA General Hospital, Beijing, China. luyinying1973@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yu, H., Yu, H., Sun, Y., Wang, F. S., & Lu, Y. (2025). Chinese expert consensus on clinical management of hepatopathy-related thrombocytopenia (2023 edition). Hepatology International. https://doi.org/10.1007/s12072-024-10755-6
Vancouver
Yu H, Yu H, Sun Y, Wang FS, Lu Y. Chinese expert consensus on clinical management of hepatopathy-related thrombocytopenia (2023 edition). Hepatology International. 2025. doi:10.1007/s12072-024-10755-6
BibTeX
@article{Yu2025,
author = {Yu, Hang and Yu, Hongli and Sun, Yao and Wang, Fu-Sheng and Lu, Yinying},
title = {Chinese expert consensus on clinical management of hepatopathy-related thrombocytopenia (2023 edition)},
journal = {Hepatology International},
year = {2025},
doi = {10.1007/s12072-024-10755-6}
}
EUVIMED